ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2021

Gastrointestinal Tolerability of Once-Weekly Dulaglutide 3.0 mg and 4.5 mg: A Post Hoc Analysis of the Incidence and Prevalence of Nausea, Vomiting, and Diarrhea in AWARD-11.

Joanna Van et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.